ZGT -- Briganti 2012
Research authors: None
Details
Download

Discrimination

Rows included 108
C-index 0.7 | 95% CI: 0.6017 - 0.8053 ROC
Brier score Not specified
Scaled Brier score Not specified

Classification plot

Not specified

Calibration

Regression coefficient 0.6
Intercept 0.17
Hosmer-Lemeshow GOF Not specified
 

Calibration plot

Histogram

Not specified

Decision curve

Not specified
Comparison
Original study population: 588
Validation study population: 108

Categorical characteristics

Name Subset / Group Nr. of patients Validation P-Value
Clinical stage T1 373 Not available
T2 184
T3 31
Primary Gleason Grade ≤3 488 Not available
≥4 100
Secondary Gleason Grade ≤3 406 Not available
≥4 182
Pathologic stage pT2 431 Not available
pT3a 97
pT3b 58
pT4 2
Pathologic Gleason Score 2-6 223 Not available
7 282
8-10 63
Missing 20

Continuous characteristics

Name LL Q1 Median Q3 UL Unit
Original Validation Age
60.3
65.9
70.4

Year
Original Validation PSA level
4.8
6.3
8.9

ng/ml
Original Validation No. of cores taken
13
16.5
24

Cores
Original Validation No of positive cores
3
6
10

Cores
Original Validation Percentage of positive cores
16.7
35.5
60.8

%
Original Validation No. of removed and examined lymph nodes
15
19
25

Positive lymph nodes
Original Validation No. of positive lymph nodes in patients with LN1
1
2
3

Positive lymph nodes
Comments
Comment
Please enter a comment
Comments are visible to anyone

Model feedback

No feedback yet 1 Comment {{ comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
Evidencio v3.25 © 2015 - 2024 Evidencio. All Rights Reserved